Adaptive randomization in clinical trials: a placebo compromise

By Wood A.   Faries D.   Heiligenstein J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 257-258

Elsevier

Access to resources Recommend Favorite

Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe

By Fleischhacker Wolfgang   Burns Tom    

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 82-84

Springer Publishing Company

Access to resources Recommend Favorite

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression

By Leuchter Andrew   Morgan Melinda   Cook Ian   Dunkin Jennifer   Abrams Michelle   Witte Elise  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 15-22

Springer Publishing Company

Access to resources Recommend Favorite

Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A Matching-Adjusted Indirect Comparison of Randomized Trials

By Signorovitch James E.  

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 665-674

Adis International

Access to resources Recommend Favorite

Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study

By Cai Yun   Chai Dong   Falagas Matthew E   Karageorgopoulos Drosos E   Wang Rui   Bai Nan   Liang Beibei  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 309-315

Informa Healthcare

Access to resources Recommend Favorite